Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 203826 / DOSAGE - SOLUTION;INTRAVENOUS - 100MG/10ML (10MG/ML)
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| PHENYLEPHRINE HYDROCHLORIDE(UNII: 04JA59TNSJ) (PHENYLEPHRINE - UNII:1WS297W6MV) | PHENYLEPHRINE HYDROCHLORIDE | 10mg in 1 |
Inactive Ingredients
| Ingredient Name | Avadel Legacy Pharmaceuticals, LLC | Accord Healthcare, Inc. | BluePoint Laboratories | Cardinal Health | Cipla USA Inc. | General Injectables & Vaccines, Inc | Hikma Pharmaceuticals USA Inc. | Ingenus Pharmaceuticals, LLC | Medical Purchasing Solutions, LLC | REMEDYREPACK INC. |
|---|---|---|---|---|---|---|---|---|---|---|
| CITRIC ACID MONOHYDRATE (2968PHW8QP) | ||||||||||
| CITRIC ACID MONOHYDRATE(2968PHW8QP) | ||||||||||
| EDETATE DISODIUM(7FLD91C86K) | ||||||||||
| HYDROCHLORIC ACID(QTT17582CB) | ||||||||||
| SODIUM CHLORIDE(451W47IQ8X) | ||||||||||
| SODIUM CITRATE(1Q73Q2JULR) | ||||||||||
| SODIUM HYDROXIDE(55X04QC32I) | ||||||||||
| SODIUM METABISULFITE (4VON5FNS3C) | ||||||||||
| SODIUM METABISULFITE(4VON5FNS3C) | ||||||||||
| TRISODIUM CITRATE DIHYDRATE(B22547B95K) | ||||||||||
| WATER(059QF0KO0R) |
